Companies: 10,795·Total market cap: $144.5T
Bio-Techne Corporation

Bio-Techne Corporation

TECHNASDAQHealthcare● Active
$51.99
$-1.19(-2.24%)
Market Cap$8.1B
P/E Ratio—
52W High$72.16
52W Low$43.2
SEC Filings

Bio-Techne Corporation (TECH) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000842023 · TECH · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,003+
Total Filings
4
Latest Form
2026-06-04
Most Recent
1989
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000842023 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-08-22
Fiscal Year End
Aug 22, 2025
Accession No.
0001558370-25-011716
Primary Document
tech-20250630x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000842023 · Accession 0001558370-25-011716

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-06Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-06-01
View
10-QQuarterly Report
10-Q
2026-05-06
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-06
View
8-KCurrent Report
8-K
2026-05-06
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
3Initial Statement of Beneficial Ownership
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-03-04
View
8-KCurrent Report
8-K
2026-02-11
View
10-QQuarterly Report
10-Q
2026-02-04
View
8-KCurrent Report
8-K
2026-02-04
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-14
View
10-QQuarterly Report
10-Q
2025-11-05
View
8-KCurrent Report
8-K
2025-11-05
View
ARSARS
ANNUAL REPORT TO SECURITY HOLDERS
2025-09-19
View
DEFA14AProxy Statement (Additional)
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
2025-09-19
View
Showing 1–15 of 434 filingsForm 4 / 144 hidden· 1003 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000842023  |  Exchange: NASDAQ · Healthcare

Bio-Techne Corporation (NASDAQ: TECH) has submitted 1,003+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1989. As a Healthcare sector company with CIK 0000842023, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Bio-Techne Corporation's most comprehensive regulatory disclosure. The most recent Bio-Techne Corporation 10-K was filed on 2025-08-22 for fiscal year ending 2025. Historical TECH 10-K annual reports are available from 2006 through 2025.

Investors researching Bio-Techne Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RVMD SEC Filings →MRNA SEC Filings →JAZZ SEC Filings →EXEL SEC Filings →MDGL SEC Filings →BMRN SEC Filings →CORT SEC Filings →QGEN SEC Filings →
→ TECH Financials→ TECH Earnings→ TECH Insider Trades

Frequently Asked Questions

TECH SEC Filings · 8 questions

Bio-Techne Corporation (TECH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,003+ filings and access original documents at no cost. Bio-Techne Corporation's CIK is 0000842023.

TECH SEC filingsBio-Techne Corporation SEC documentsfind TECH 10-K